Skip to main content

White paper

New dimensions in life sciences research

Proving the impact on clinical outcomes as well as costs.

Using integrated data to create a dimensional view of outcomes and cost

Integrating data at scale is growing easier with advances in de-identification software, development of certified data models to protect privacy, and cloud-based computing. The resulting value is a dimensional view of outcomes and cost. Traditional analysis leaves vital information out of the value equation.

Improve decisions, enrich research and strengthen strategies

Life sciences research is benefiting from the powerful addition of integrated data. Researchers can now gain data in sufficient amounts to power robust analytics. This white paper explores how this new data can improve early business decisions, enrich research activity and strengthen market strategies.

Related healthcare insights

View all

Article

Rethinking clinical trial recruitment: Adapting to real-world data

Clinical trial recruitment shortfalls are often the result of protocol designs that don’t reflect how care is delivered. Real-world data can make a transformative difference.

Article

How real-world evidence can inform pharma strategies in 2025

Health economics and outcomes research (HEOR) can play a key role in helping the life sciences industry improve patient outcomes.

Article

Tips for selecting a fit for purpose data set

Using real-world data (RWD) that are not fit for purpose can waste time and money. Review 6 simple steps to guide your research towards the right data.